Ignite Creation Date:
2024-05-05 @ 11:07 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00005859
Status:
COMPLETED
Last Update Posted:
2018-06-26
First Post:
2000-06-02
Brief Title:
Tipifarnib in Treating Patients With Recurrent or Progressive Malignant Glioma
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization Data
Organization:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Class:
OTHER
Study ID:
NABTC-9901
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |